Surgery News and Research

RSS

AMDL submits data to FDA for clearance to market its diagnostic test to monitor colorectal cancer patients

AMDL, Inc., developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has filed with the U.S. Food & Drug Administration (FDA) for clearance to market its unique, proprietary DR-70 (FDP) ELISA tumor marker test for use as an aid in monitoring patients previously diagnosed with colorectal cancer. AMDL used the guidance provided at the meeting they had with the FDA on January 25, 2007.

15 Oct 2007

Penn awarded $2.1 million grant for cardiovascular research

Cardiac researchers at the University of Pennsylvania have received a $2.1 million grant from the National Institutes of Health (NIH) to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.

12 Oct 2007

Pioneering approach to cardiovascular care

Thousands of heart patients in the Greater New York region will receive top quality, comprehensive cardiac care in an innovative cardiovascular program in which physicians at a major academic medical center will receive incentive payments based on 60 performance measures for outpatient and inpatient care.

12 Oct 2007

A tumor-blocking protein may be key in developing deadly form of pancreatic cancer

A tumor-blocking protein previously implicated in prostate and breast cancer development may also be behind the most aggressive type of pancreatic cancer. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered that the protein pp32 – which normally applies the brakes on a cancer-causing gene – is missing in an aggressive form of pancreatic cancer.

12 Oct 2007

Genome update defines landscape of breast and colon cancers

One year after completing the first large-scale report sequencing breast and colon cancer genes, Johns Hopkins Kimmel Cancer Center scientists have studied the vast majority of protein-coding genes which now suggest a landscape dominated by genes that each are mutated in relatively few cancers.

12 Oct 2007

Breast cancer awareness calls for cardiovascular awareness

Women who overcome breast cancer have every reason to celebrate. But a heart filled with joy may also be a heart damaged by life-saving cancer therapies, a growing body of research shows.

12 Oct 2007

Aida granted new anti-cancer patent

One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.

12 Oct 2007

Trial results of lovaxin C in advanced cervical cancer patients

A first-in-man trial of a live Listeria vaccine was reported by Advaxis Inc. The Phase I/II trial was testing Lovaxin C in advanced cervical cancer patients.

10 Oct 2007

18F-DG PET/CT can highly increase the detection of colorectal cancer

Combined positron emission tomography and computed tomography (PET/CT) is currently widely used in the clinical diagnosis of cancer to provide functional and morphological imaging.

10 Oct 2007

Women on low-fat diets reduce their risk of ovarian cancer

The American Cancer Society, estimates that as many as 22,400 women in the United States will be diagnosed with ovarian cancer this year and of that number around 15,200 will die from the disease.

10 Oct 2007

African-American men have a slightly higher risk of PSA recurrence

African-American men are more likely to have their prostate cancer return after treatment, but their disease is no more aggressive when it does recur than that of their white counterparts, according to a study led by Duke Prostate Center researchers.

10 Oct 2007

Broncus Technologies reports positive results for airway bypass procedure for the treatment of emphysema

Broncus Technologies, Inc., a medical device company investigating the airway bypass procedure for the treatment of emphysema, has announced that the results of its open-label Exhale Drug-Eluting Stent feasibility study have been published in the October issue of the Journal of Thoracic and Cardiovascular Surgery.

10 Oct 2007

M-POSSUM evaluation system improves accuracy and effectiveness of the original system

Based on POSSUM, a system suggested by some British scholars more than 10 years ago, a team led by Dr. Lian-An Ding has established the M-POSSUM evaluation system with the aim of improving the accuracy and effectiveness of the original system.

10 Oct 2007

Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals

The Department of Radiology and Physical Medicine of the Universidad de Granada, in Andalusian hospitals radiotherapy is not used as much as should be expected for the treatment of cancer, in favour of other procedures such as chemotherapy or surgery.

10 Oct 2007

TB patient jailed in the U.S flees 'abuse' for safety of Russia

A tuberculosis patient, confined in a hospital jail ward in Arizona since August 2006 has fled the country apparently because he could no longer tolerate the abuse metered out to him.

9 Oct 2007

African-American women less likely to have adjuvant cancer therapy than white women

A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.

9 Oct 2007

Xeloda (capecitabine) better all round for cancer patients

A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.

9 Oct 2007

Surgery may offer best chance of long-term prostate cancer survival

A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

9 Oct 2007

Surgery for prostate cancer appear to offer greatest survival chance

9 Oct 2007

New LED technology for deep cordless surgery

Enova Medical Technologies has announced that it has developed new LED technology for cordless surgical headlights that, for the first time ever, reaches light output levels exceeding 200,000 lux at 14 inches.

9 Oct 2007